［1］汤泽中，周丛乐，姜毅，侯新琳. 新生儿脑梗死的临床特征及其与预后关系的研究［J］. 中华儿科杂志，2004，42（6）：429-432.

［2］富建华，毛健，薛辛东，由凯. 磁共振弥散加权成像在新生儿脑梗死早确诊断中的意义及其变化规律［J］. 中华儿科杂志，2007，45(5)：360-364.

 ［3］李丽华，母得志，屈艺. 新生儿卒中的发病机制研究进展［J］．国际儿科学杂志，2006，33（4）：225-227

 ［4］Guther G, Junker R, Strater R, Schobess R, Kurnik K, Heller C, et al. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors［J］. Stroke, 2000, 31(10): 2437-2441.

 ［5］Simchen MJ, Goldstein G, Lubetsky A, Strauss T, Schiff E, Kenet G. Factor V Leiden and antiphospholipid antibodies in either mothers or infants increase the risk for perinatal arterial ischemic stroke［J］. Stroke, 2009, 40(1): 65-70.

［6］Kirton A, deVeber G. Advances in perinatal ischemic stroke［J］. Pediatr Neurol, 2009, 40(3): 205-214.

［7］Lee J, Croen LA, Backstrand KH, Yoshida CK, Henning LH, Lindan C, et al. Maternal and infant characteristics associated with perinatal arterial stroke in the infant［J］. JAMA, 2005, 293(6): 723-729.

［8］Grabowski EF, Buonanno FS, Krishnamoorthy K. Prothrombotic risk factors in the evaluation and management of perinatal stroke［J］. Semin Perinatol, 2007, 31(4): 243-249.

［9］Benders MJ, Groenendaal F, Uiterwaal CS, de Vries LS. Perinatal arterial stroke in the preterm infant［J］. Semin Perinatol, 2008, 32(5): 344-349.

［10］Kurnik K, Kosch A, Strater R, Schobess R, Heller C, Nowak-Gottl U. Recurrent thromboembolismin infants and children suffering from symptomatic neonatal arterial stroke: a prospective follow-up study［J］. Stroke, 2003, 34(12): 2887-2892.

［11］Koppelman SJ, Van′t Veer C, Sixma JJ, Bouma BN. Synergistic inhibition of the intrinsic factor X activation by protein S and C4b-binding protein［J］. Blood, 1995, 86(7): 2653-2660.